Indeed, a few studies have used mass spectrometric metabolomics to identify COVID-19-induced alterations in circulating metabolites, focusing on the correlation of such parameters with clinical presentation10, circulating interleukin (IL)-6 concentrations11 or male sex12. The gene discussed is IL6; the disease is COVID-19.